{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05802238",
            "orgStudyIdInfo": {
                "id": "2021-153"
            },
            "organization": {
                "fullName": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)",
                "class": "OTHER"
            },
            "briefTitle": "Efficacy of Tranexamic Acid (TXA) in Humerus ORIF",
            "officialTitle": "Efficacy of Tranexamic Acid (TXA) in Humerus ORIF",
            "acronym": "TXA",
            "therapeuticArea": [
                "Orthopedics"
            ],
            "study": "efficacy-of-tranexamic-acid-txa-in-humerus-orif"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-04-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-08",
            "studyFirstSubmitQcDate": "2023-04-05",
            "studyFirstPostDateStruct": {
                "date": "2023-04-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Peter Tang",
                "investigatorTitle": "Associate Professor of Orthopaedic Surgery",
                "investigatorAffiliation": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)"
            },
            "leadSponsor": {
                "name": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine if administration of tranexamic acid (TXA), a clotting agent, will decrease blood loss, the need for transfusion, and reduce the likelihood of wound complications such as infection. Investigators will also see if the drug can effectively decrease operative time and length of hospitalization.",
            "detailedDescription": "Single-center randomized controlled trial, parallel two-arm design allocation 1:1 exposed-control design to determine if TXA aids in prevention of blood loss in upper extremity trauma, specifically humerus fractures. Patient population includes male and female adults with no history of thromboses who suffered an isolated humeral injury. Patients will be evaluated at Allegheny General Hospital (AGH) as surgical candidates and allocated to the exposure group (receive TXA) or the control group (saline placebo). Patients randomized to treatment arm of study will have TXA administered 10 minutes prior to surgery. The control group will have saline administered 10 minutes prior to surgery. Patients will be seen in follow up at both 2 weeks and 6 weeks postoperatively, as well as followed through the electronic medical record (EMR)."
        },
        "conditionsModule": {
            "conditions": [
                "Fracture Humerus"
            ],
            "keywords": [
                "Open Reduction Internal Fixation",
                "Blood loss"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Single-center randomized controlled trial, parallel two-arm design allocation 1:1 exposed-control design",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 130,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment Arm",
                    "type": "EXPERIMENTAL",
                    "description": "Patients randomized to treatment arm of study will have TXA administered 10 minutes prior to surgery",
                    "interventionNames": [
                        "Drug: Tranexamic acid (TXA)"
                    ]
                },
                {
                    "label": "Control Group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "The control group will have saline administered 10 minutes prior to surgery.",
                    "interventionNames": [
                        "Other: Saline"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tranexamic acid (TXA)",
                    "description": "1 gram of TXA in 10mg single-dose ampule (100mg/mL) administered 10 minutes prior to surgery",
                    "armGroupLabels": [
                        "Treatment Arm"
                    ],
                    "otherNames": [
                        "Tranexamic acid"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Saline",
                    "description": "control group will receive 10 mL of normal saline infused intravenously at 1 mL/min.",
                    "armGroupLabels": [
                        "Control Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Blood loss",
                    "description": "The estimated total blood loss measured intraoperatively. This will be done by estimating absorbed drainage by surgical gauze and adding this to total volume in suction canister. Total volume of irrigation used will be subtracted from this total to give an estimate of intraoperative blood loss.",
                    "timeFrame": "Intraoperatively"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Operative Time",
                    "description": "Amount of time of operative procedure",
                    "timeFrame": "From the start of surgical procedure through the completion of the surgical procedure"
                },
                {
                    "measure": "Duration of follow-up",
                    "description": "Through study completion, an average of one year.",
                    "timeFrame": "Through study completion, an average of one year."
                },
                {
                    "measure": "Complications (DVT, PE, stroke)",
                    "description": "Presence or absence of the monitored complications (DVT, PE, stroke) will be recorded as a categorical data value.",
                    "timeFrame": "through study completion, an average of one year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Males or females age 18-100 years\n2. Isolated proximal humerus or humeral shaft fracture undergoing open reduction internal fixation.\n3. Must be able to read and understand English and consent for themselves.\n\nExclusion Criteria:\n\n1. Allergy to TXA.\n2. Acquired disturbances of color vision.\n3. History of arterial or venous thromboembolic disease; such as DVT, PE, CVA, TIA.\n4. Pregnant or breastfeeding.\n5. Recent MI (within 6 months of surgery) or any placement of stent regardless of time since placement.\n6. Renal impairment (creatinine above 1.2 in women, creatinine above 1.4 in men)\n7. Refusal of blood products\n8. Subarachnoid hemorrhage\n9. Disseminated intravascular coagulation",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "100 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials",
                    "role": "CONTACT",
                    "phone": "412-330-6151",
                    "email": "clinicaltrials@ahn.org"
                },
                {
                    "name": "Peter Tang, MD",
                    "role": "CONTACT",
                    "phone": "412-359-8098",
                    "email": "Peter.Tang@ahn.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Peter Tang, MD",
                    "affiliation": "Allegheny Health Network Allegheny General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Allegheny Health Network Allegheny General Hospital",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15212",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Peter Tang, MD",
                            "role": "CONTACT",
                            "phone": "412-359-8098",
                            "email": "Peter.Tang@ahn.org"
                        },
                        {
                            "name": "Peter Tang, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Daniel Altman, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Gregory Altman, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Steven Regal, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Edward Westrick, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "28562553",
                    "type": "BACKGROUND",
                    "citation": "Sun CX, Zhang L, Mi LD, Du GY, Sun XG, He SW. Efficiency and safety of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A systematic review and meta-analysis. Medicine (Baltimore). 2017 Jun;96(22):e7015. doi: 10.1097/MD.0000000000007015."
                },
                {
                    "pmid": "27435332",
                    "type": "BACKGROUND",
                    "citation": "Akgul T, Buget M, Salduz A, Edipoglu IS, Ekinci M, Kucukay S, Sen C. Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: A prospective clinical study. Acta Orthop Traumatol Turc. 2016 Aug;50(4):429-31. doi: 10.1016/j.aott.2016.06.007. Epub 2016 Jul 16."
                },
                {
                    "pmid": "25617507",
                    "type": "BACKGROUND",
                    "citation": "Cheriyan T, Maier SP 2nd, Bianco K, Slobodyanyuk K, Rattenni RN, Lafage V, Schwab FJ, Lonner BS, Errico TJ. Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J. 2015 Apr 1;15(4):752-61. doi: 10.1016/j.spinee.2015.01.013. Epub 2015 Jan 21."
                },
                {
                    "pmid": "31902124",
                    "type": "BACKGROUND",
                    "citation": "Yu X, Wang J, Wang X, Xie L, Chen C, Zheng W. The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. J Thromb Thrombolysis. 2020 Aug;50(2):243-257. doi: 10.1007/s11239-019-02034-1."
                },
                {
                    "pmid": "30939507",
                    "type": "BACKGROUND",
                    "citation": "Spitler CA, Row ER, Gardner WE 2nd, Swafford RE, Hankins MJ, Nowotarski PJ, Kiner DW. Tranexamic Acid Use in Open Reduction and Internal Fixation of Fractures of the Pelvis, Acetabulum, and Proximal Femur: A Randomized Controlled Trial. J Orthop Trauma. 2019 Aug;33(8):371-376. doi: 10.1097/BOT.0000000000001480."
                },
                {
                    "pmid": "28983887",
                    "type": "BACKGROUND",
                    "citation": "Baskaran D, Rahman S, Salmasi Y, Froghi S, Berber O, George M. Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis. Hip Int. 2018 Jan;28(1):3-10. doi: 10.5301/hipint.5000556."
                },
                {
                    "pmid": "28938281",
                    "type": "BACKGROUND",
                    "citation": "Gausden EB, Qudsi R, Boone MD, O'Gara B, Ruzbarsky JJ, Lorich DG. Tranexamic Acid in Orthopaedic Trauma Surgery: A Meta-Analysis. J Orthop Trauma. 2017 Oct;31(10):513-519. doi: 10.1097/BOT.0000000000000913."
                },
                {
                    "pmid": "29337665",
                    "type": "BACKGROUND",
                    "citation": "Franchini M, Mengoli C, Marietta M, Marano G, Vaglio S, Pupella S, Mannucci PM, Liumbruno GM. Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus. 2018 Jan;16(1):36-43. doi: 10.2450//2017.0219-17."
                },
                {
                    "pmid": "28283245",
                    "type": "BACKGROUND",
                    "citation": "Hooda B, Chouhan RS, Rath GP, Bithal PK, Suri A, Lamsal R. Effect of tranexamic acid on intraoperative blood loss and transfusion requirements in patients undergoing excision of intracranial meningioma. J Clin Neurosci. 2017 Jul;41:132-138. doi: 10.1016/j.jocn.2017.02.053. Epub 2017 Mar 7."
                },
                {
                    "pmid": "29757132",
                    "type": "BACKGROUND",
                    "citation": "Franchini M, Mengoli C, Cruciani M, Bergamini V, Presti F, Marano G, Pupella S, Vaglio S, Masiello F, Veropalumbo E, Piccinini V, Pati I, Liumbruno GM. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus. 2018 Jul;16(4):329-337. doi: 10.2450/2018.0026-18. Epub 2018 Apr 3."
                },
                {
                    "pmid": "27626017",
                    "type": "BACKGROUND",
                    "citation": "Ali Algadiem E, Aleisa AA, Alsubaie HI, Buhlaiqah NR, Algadeeb JB, Alsneini HA. Blood Loss Estimation Using Gauze Visual Analogue. Trauma Mon. 2016 May 3;21(2):e34131. doi: 10.5812/traumamon.34131. eCollection 2016 May."
                },
                {
                    "pmid": "30516625",
                    "type": "BACKGROUND",
                    "citation": "Goobie SM, Zurakowski D, Glotzbecker MP, McCann ME, Hedequist D, Brustowicz RM, Sethna NF, Karlin LI, Emans JB, Hresko MT. Tranexamic Acid Is Efficacious at Decreasing the Rate of Blood Loss in Adolescent Scoliosis Surgery: A Randomized Placebo-Controlled Trial. J Bone Joint Surg Am. 2018 Dec 5;100(23):2024-2032. doi: 10.2106/JBJS.18.00314."
                },
                {
                    "pmid": "32713466",
                    "type": "BACKGROUND",
                    "citation": "Cuff DJ, Simon P, Gorman RA 2nd. Randomized prospective evaluation of the use of tranexamic acid and effects on blood loss for proximal humeral fracture surgery. J Shoulder Elbow Surg. 2020 Aug;29(8):1627-1632. doi: 10.1016/j.jse.2020.04.016. Epub 2020 Jun 9."
                },
                {
                    "pmid": "33194102",
                    "type": "BACKGROUND",
                    "citation": "Yang YY, Qin H, Zheng X, Hu B, Zhang M, Ma T. Administration of Tranexamic Acid in Proximal Humeral Fractures. Indian J Orthop. 2020 May 11;54(Suppl 2):277-282. doi: 10.1007/s43465-020-00128-0. eCollection 2020 Dec."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006810",
                    "term": "Humeral Fractures"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001134",
                    "term": "Arm Injuries"
                },
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                },
                {
                    "id": "D000050723",
                    "term": "Fractures, Bone"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M26370",
                    "name": "Fractures, Bone",
                    "relevance": "LOW"
                },
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "relevance": "LOW"
                },
                {
                    "id": "M9869",
                    "name": "Humeral Fractures",
                    "asFound": "Fracture Humerus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4444",
                    "name": "Arm Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014148",
                    "term": "Tranexamic Acid"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000933",
                    "term": "Antifibrinolytic Agents"
                },
                {
                    "id": "D000050299",
                    "term": "Fibrin Modulating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006490",
                    "term": "Hemostatics"
                },
                {
                    "id": "D000003029",
                    "term": "Coagulants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16902",
                    "name": "Tranexamic Acid",
                    "asFound": "Non-Small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4252",
                    "name": "Antifibrinolytic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9576",
                    "name": "Hemostatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M6259",
                    "name": "Coagulants",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}